Stock listing
KRX:207940 Samsung Biologics Co., Ltd. (삼성바이오로직스) 주가
Follow Samsung Biologics Co., Ltd. into a list and get an email when it puts out news.
Share price · KRX:207940
₩1,422,000 KRW -65,000 (-4.4%)
Close on Nov 2, 2026
- Day range
- ₩1,420,000 – ₩1,473,000 KRWNov 2, 2026
- Volume
- 40,959 sharesNov 2, 2026
- Market cap
- ₩66.20T KRWAt the close on Nov 2, 2026 · price × 46.55M shares outstanding
- Traded on an average day
- ₩78.77B KRWMedian day 48,730 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · KRX:207940 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩1,422,000 | -65,000 | -4.4% | ₩1,446,000 | ₩1,473,000 | ₩1,420,000 | 40,959 | |
| ₩1,487,000 | +121,000 | +8.9% | ₩1,380,000 | ₩1,487,000 | ₩1,350,000 | 99,252 | |
| ₩1,366,000 | -6,000 | -0.4% | ₩1,381,000 | ₩1,391,000 | ₩1,350,000 | 41,383 | |
| ₩1,372,000 | -2,000 | -0.1% | ₩1,370,000 | ₩1,399,000 | ₩1,360,000 | 49,167 | |
| ₩1,374,000 | -78,000 | -5.4% | ₩1,437,000 | ₩1,438,000 | ₩1,353,000 | 89,610 | |
| ₩1,452,000 | -14,000 | -1.0% | ₩1,446,000 | ₩1,489,000 | ₩1,441,000 | 33,925 | |
| ₩1,466,000 | +105,000 | +7.7% | ₩1,385,000 | ₩1,475,000 | ₩1,371,000 | 114,596 | |
| ₩1,361,000 | -56,000 | -4.0% | ₩1,397,000 | ₩1,417,000 | ₩1,355,000 | 56,156 | |
| ₩1,417,000 | +26,000 | +1.9% | ₩1,405,000 | ₩1,449,000 | ₩1,384,000 | 81,496 | |
| ₩1,391,000 | -36,000 | -2.5% | ₩1,420,000 | ₩1,440,000 | ₩1,370,000 | 91,619 | |
| ₩1,427,000 | +129,000 | +9.9% | ₩1,290,000 | ₩1,432,000 | ₩1,269,000 | 131,839 | |
| ₩1,298,000 | +51,000 | +4.1% | ₩1,241,000 | ₩1,337,000 | ₩1,216,000 | 156,324 | |
| ₩1,247,000 | +65,000 | +5.5% | ₩1,165,000 | ₩1,250,000 | ₩1,150,000 | 139,442 | |
| ₩1,182,000 | -24,000 | -2.0% | ₩1,198,000 | ₩1,200,000 | ₩1,165,000 | 54,896 | |
| ₩1,206,000 | +5,000 | +0.4% | ₩1,196,000 | ₩1,207,000 | ₩1,165,000 | 62,502 | |
| ₩1,201,000 | -18,000 | -1.5% | ₩1,216,000 | ₩1,217,000 | ₩1,179,000 | 60,946 | |
| ₩1,219,000 | -58,000 | -4.5% | ₩1,273,000 | ₩1,274,000 | ₩1,218,000 | 81,929 | |
| ₩1,277,000 | -33,000 | -2.5% | ₩1,303,000 | ₩1,313,000 | ₩1,272,000 | 62,482 | |
| ₩1,310,000 | -44,000 | -3.2% | ₩1,355,000 | ₩1,363,000 | ₩1,300,000 | 84,657 | |
| ₩1,354,000 | -65,364 | -4.6% | ₩1,428,000 | ₩1,429,000 | ₩1,350,000 | 51,556 | |
| ₩1,419,364 | +37,744 | +2.7% | ₩1,380,627 | ₩1,431,283 | ₩1,379,634 | 56,055 | |
| ₩1,381,620 | +5,960 | +0.4% | ₩1,379,634 | ₩1,395,526 | ₩1,356,789 | 49,297 | |
| ₩1,375,661 | -14,899 | -1.1% | ₩1,376,654 | ₩1,380,627 | ₩1,352,816 | 31,080 | |
| ₩1,390,560 | +24,560 | +1.8% | ₩1,357,782 | ₩1,396,519 | ₩1,356,789 | 49,188 | |
| ₩1,366,000 | -25,000 | -1.8% | ₩1,390,000 | ₩1,394,000 | ₩1,360,000 | 38,947 | |
| ₩1,391,000 | -11,000 | -0.8% | ₩1,407,000 | ₩1,408,000 | ₩1,389,000 | 30,116 | |
| ₩1,402,000 | +4,000 | +0.3% | ₩1,398,000 | ₩1,410,000 | ₩1,389,000 | 30,180 | |
| ₩1,398,000 | +2,000 | +0.1% | ₩1,407,000 | ₩1,414,000 | ₩1,386,000 | 34,673 | |
| ₩1,396,000 | -13,000 | -0.9% | ₩1,415,000 | ₩1,422,000 | ₩1,392,000 | 30,353 | |
| ₩1,409,000 | -3,000 | -0.2% | ₩1,415,000 | ₩1,415,000 | ₩1,394,000 | 33,593 | |
| ₩1,412,000 | -8,000 | -0.6% | ₩1,406,000 | ₩1,428,000 | ₩1,403,000 | 24,761 | |
| ₩1,420,000 | +5,000 | +0.4% | ₩1,400,000 | ₩1,438,000 | ₩1,381,000 | 32,516 | |
| ₩1,415,000 | -8,000 | -0.6% | ₩1,406,000 | ₩1,423,000 | ₩1,396,000 | 26,885 | |
| ₩1,423,000 | -29,000 | -2.0% | ₩1,437,000 | ₩1,444,000 | ₩1,414,000 | 60,397 | |
| ₩1,452,000 | +12,000 | +0.8% | ₩1,441,000 | ₩1,454,000 | ₩1,436,000 | 25,981 | |
| ₩1,440,000 | -26,000 | -1.8% | ₩1,475,000 | ₩1,479,000 | ₩1,439,000 | 30,465 | |
| ₩1,466,000 | +19,000 | +1.3% | ₩1,455,000 | ₩1,466,000 | ₩1,446,000 | 32,116 | |
| ₩1,447,000 | -30,000 | -2.0% | ₩1,484,000 | ₩1,487,000 | ₩1,433,000 | 45,399 | |
| ₩1,477,000 | -24,000 | -1.6% | ₩1,501,000 | ₩1,505,000 | ₩1,451,000 | 34,227 | |
| ₩1,501,000 | -19,000 | -1.3% | ₩1,493,000 | ₩1,519,000 | ₩1,490,000 | 36,243 | |
| ₩1,520,000 | +2,000 | +0.1% | ₩1,500,000 | ₩1,520,000 | ₩1,497,000 | 29,197 | |
| ₩1,518,000 | +32,000 | +2.2% | ₩1,481,000 | ₩1,518,000 | ₩1,448,000 | 86,767 | |
| ₩1,486,000 | -108,000 | -6.8% | ₩1,507,000 | ₩1,540,000 | ₩1,480,000 | 111,160 | |
| ₩1,594,000 | -5,000 | -0.3% | ₩1,602,000 | ₩1,611,000 | ₩1,584,000 | 29,767 | |
| ₩1,599,000 | +14,000 | +0.9% | ₩1,599,000 | ₩1,611,000 | ₩1,577,000 | 40,816 | |
| ₩1,585,000 | +12,000 | +0.8% | ₩1,551,000 | ₩1,596,000 | ₩1,537,000 | 42,479 | |
| ₩1,573,000 | +22,000 | +1.4% | ₩1,559,000 | ₩1,575,000 | ₩1,543,000 | 32,870 | |
| ₩1,551,000 | -23,000 | -1.5% | ₩1,539,000 | ₩1,564,000 | ₩1,530,000 | 44,704 | |
| ₩1,574,000 | +30,000 | +1.9% | ₩1,622,000 | ₩1,645,000 | ₩1,546,000 | 62,565 | |
| ₩1,544,000 | +13,000 | +0.8% | ₩1,507,000 | ₩1,544,000 | ₩1,486,000 | 28,670 | |
| ₩1,531,000 | -17,000 | -1.1% | ₩1,533,000 | ₩1,542,000 | ₩1,515,000 | 37,718 | |
| ₩1,548,000 | -16,000 | -1.0% | ₩1,557,000 | ₩1,574,000 | ₩1,546,000 | 29,916 | |
| ₩1,564,000 | +15,000 | +1.0% | ₩1,556,000 | ₩1,571,000 | ₩1,531,000 | 55,792 | |
| ₩1,549,000 | -60,000 | -3.7% | ₩1,609,000 | ₩1,628,000 | ₩1,545,000 | 69,313 | |
| ₩1,609,000 | +40,000 | +2.5% | ₩1,571,000 | ₩1,623,000 | ₩1,567,000 | 69,856 | |
| ₩1,569,000 | +13,000 | +0.8% | ₩1,556,000 | ₩1,572,000 | ₩1,532,000 | 42,211 | |
| ₩1,556,000 | +42,000 | +2.8% | ₩1,503,000 | ₩1,556,000 | ₩1,490,000 | 51,786 | |
| ₩1,514,000 | +23,000 | +1.5% | ₩1,505,000 | ₩1,514,000 | ₩1,477,000 | 48,730 | |
| ₩1,491,000 | +15,000 | +1.0% | ₩1,473,000 | ₩1,519,000 | ₩1,473,000 | 52,180 | |
| ₩1,476,000 | +53,000 | +3.7% | ₩1,424,000 | ₩1,476,000 | ₩1,406,000 | 51,711 | |
| ₩1,423,000 | -62,000 | -4.2% | ₩1,473,000 | ₩1,473,000 | ₩1,411,000 | 47,113 |
- Ticker
- KRX:207940
- Asset type
- Stock
- Exchange
- KRX
- Currency
- KRW
What changed lately
Latest news release · Oct 13, 2026
PolyPeptide Group: Provisional interim result of the public tender offer of Samsung Biologics Co., Ltd.
Latest news
PolyPeptide Group: Provisional interim result of the public tender offer of Samsung Biologics Co., Ltd.
Oct 13, 2026
Closed ₩1,206,000 (+0.4%) on Oct 13, 2026
Samsung Biologics publishes prospectus for PolyPeptide public tender offer
Aug 31, 2026
Closed ₩1,518,000 (+2.2%) on Aug 31, 2026
Samsung Biologics Reports Second Quarter 2026 Financial Results
Jul 23, 2026
Closed ₩1,379,000 (+0.5%) on Jul 23, 2026
Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India
Jul 19, 2026
Closed ₩1,345,000 (-3.7%) on Jul 20, 2026
Samsung Biologics Releases 2026 ESG Report, Highlighting Progress in Sustainable Operations and Responsible Growth
Jun 30, 2026
Closed ₩1,396,000 (+0.4%) on Jul 1, 2026
2025 FY Audited Financial Statements (Consolidated)
May 20, 2026
Closed ₩1,337,000 (-0.7%) on May 20, 2026
Cartography Biosciences Announces Strategic Investment From Samsung Ventures to Advance Oncology Pipeline
May 6, 2026
Closed ₩1,468,000 (-0.8%) on May 7, 2026
Samsung Biologics Listed on Dow Jones Best-in-Class World Index for Fifth Consecutive Year
May 5, 2026
Closed ₩1,480,000 (-0.3%) on May 6, 2026
Samsung Bioepis and ATLATL Sign Memorandum of Understanding (MoU) to Accelerate Early-Stage Biotech Innovation in Asia-Pacific
Apr 29, 2026
Closed ₩1,473,000 (-2.1%) on Apr 29, 2026
Samsung Biologics Reports First Quarter 2026 Financial Results
Apr 22, 2026
Closed ₩1,561,000 (-1.7%) on Apr 22, 2026
Samsung Biologics Co., Ltd. on 6ix
- News releases
- 19 in the last 12 months · 29 in all · newest Oct 13, 2026 · oldest 2025
Log in to ask 6ix AI your own questions about Samsung Biologics Co., Ltd.